Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections. - Wikidata - wikimedia - TriplyDB

Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections.

Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections.

http://www.wikidata.org/entity/Q35102451

about

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.

P2860

Q38665181-0E707B56-3418-4940-98B0-D1F14C2E9C98 Q39026157-5B72B701-11A5-4B5E-BD1A-F1C7A5869016 Q52626852-69C78F53-1195-4C3E-9490-16DB936C99DB

P2860

Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections.

http://www.wikidata.org/entity/Q35102451

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Building and optimizing a viru ...... notherapy in viral infections.

@ast

Building and optimizing a viru ...... notherapy in viral infections.

@en

type

label

Building and optimizing a viru ...... notherapy in viral infections.

@ast

Building and optimizing a viru ...... notherapy in viral infections.

@en

prefLabel

Building and optimizing a viru ...... notherapy in viral infections.

@ast

Building and optimizing a viru ...... notherapy in viral infections.

@en

P1433

Q35102451-E495D97E-474C-4676-A996-6E6AB299A4FD

P1476

Q35102451-641BD1EC-1F7C-4ED6-85EB-9080F69BCDA1

P2093

Q35102451-1E812BFC-4A2E-4932-891F-D0EDFF6BB2D3

Q35102451-2628B3BC-B6A6-4228-B483-F43F9D14E999

Q35102451-2C479260-C12D-4139-932B-579B6A52CB0A

Q35102451-4BD019EC-C562-4ACF-A600-B0482D97AE8B

Q35102451-C01F7968-752A-49C6-B50C-372F5A4DDE88

Q35102451-D52C00F8-5E83-4229-8C6C-C6EB3591524B

Q35102451-FA5733B7-2495-4CC5-8D0B-0DF5AF5B6F5A

P2860

Q35102451-08AFD10F-FA85-42A5-AF42-17E8917868FA

Q35102451-09D985FD-726B-496F-A3F5-0B2D1A4C2973

Q35102451-139C7DBB-07C7-4A79-ABC8-4F048AE3BF1E

Q35102451-17749050-EE10-43B1-B4B7-CE5B27283956

Q35102451-19D53A8B-17B0-440C-B1CB-A197D14186A6

Q35102451-2584FC78-8BE1-4439-9302-451CF64D4F0B

Q35102451-300DD610-5448-48F5-B106-9CD3D81EDE23

Q35102451-35AB8721-A0FA-4731-B341-DC21419A0FAB

Q35102451-3B2D39C3-91C2-4435-82A2-9FAFDC3AF664

Q35102451-3D0A602B-A75A-45F5-9CCF-64ADAE2EFBF0

P2888

Q35102451-C6753DEF-3E9F-41BD-9A2F-167902C721B1

P304

Q35102451-BCA66280-29CD-4FD0-BF88-8960829B512E

P31

Q35102451-90515686-883F-4BD5-A142-DF97542C09E3

P356

Q35102451-D2412AF0-91C8-4577-9711-0EF6A41CDE35

P407

Q35102451-79243B01-86E5-4A4C-A0FF-17474C5DD146

P478

Q35102451-F8438BFD-27FC-4300-9E5B-255ED39F5BD9

P50

Q35102451-7A50CA29-A7B5-4234-AC57-2D8F6D49B0EC

P577

Q35102451-A9CA9EC4-9EA3-4D33-90FA-090697C22BD0

P5875

Q35102451-BF92E452-89B1-4092-9D79-569174CBCADB

P6179

Q35102451-980F82E0-9A64-40F0-BDBA-C465E8BB2EFF

P698

Q35102451-04A1A76C-0DBA-4A24-A7A9-4092A4D39539

P932

Q35102451-5F741A10-5BA1-481A-B24B-44E4490D4790

P356

P1433

Scientific Reports

P1476

Building and optimizing a viru ...... notherapy in viral infections.

@en

P2093

Adam J Gehring

http://www.w3.org/2001/XMLSchema#string

Adeline Chia

http://www.w3.org/2001/XMLSchema#string

Alfonso Tan Garcia

http://www.w3.org/2001/XMLSchema#string

Gijsbert M Grotenbreg

http://www.w3.org/2001/XMLSchema#string

Komathi Paravasivam

http://www.w3.org/2001/XMLSchema#string

Nasirah Banu

http://www.w3.org/2001/XMLSchema#string

Zi Zong Ho

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular immune correlates of protection against symptomatic pandemic influenza.

Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer.

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases.

Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope

Facilitating matched pairing and expression of TCR chains introduced into human T cells.

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

P2888

P304

4166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP04166

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Bertoletti

P577

2014-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260378796

http://www.w3.org/2001/XMLSchema#string

P6179

1025429918

http://www.w3.org/2001/XMLSchema#string

P698

24566718

http://www.w3.org/2001/XMLSchema#string

P932

3933865

http://www.w3.org/2001/XMLSchema#string